Position in REGN
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$1,083,241
+$1,080 QoQ
Shares Held
1,402
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vise Technologies, Inc. holds $12,234,017 across 26 Biotechnology names. REGN ranks #2 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,259 | $2,348,353 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,402 | $1,083,241 | |
| 3 | INSM |
INSMED Inc
|
6,314 | $1,032,465 | |
| 4 | PTCT |
Ptc Therapeutics, Inc.
|
9,842 | $670,535 | |
| 5 | RPRX |
Royalty Pharma plc
|
10,651 | $510,928 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,515 | $501,268 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
7,424 | $479,813 | |
| 8 | ARGX |
Argenx SE
|
620 | $452,755 |
All Filings in REGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,083,241 | 1,402 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,082,161 | 1,402 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $601,066 | 1,069 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,125,075 | 2,143 | Shares | Sole | 2025-08-07 | |
| 2024-12-31 | $559,891 | 786 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $486,724 | 463 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $239,634 | 228 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $204,047 | 212 | Shares | Sole | 2024-05-15 | |
| 2022-06-30 | $243,545 | 412 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||